Outset Medical Inc (OM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $63.98M
Last updated: Nov 17, 2026 at 4:15 PM ET
Outset Medical Inc (OM) Statistics
Outset Medical (OM) has a market cap of $63.98M and an enterprise value of $129.47M. It kept -58.33% of revenue as net income over the last 12 months. Its share count is up 5.89% from a year earlier.
Total Valuation
Enterprise value is 102.37% above the market cap, as debt exceeds cash.
| Market Cap | $63.98M |
|---|---|
| Enterprise Value | $129.47M |
| Latest price (Nov 17, 2026) | $3.16 |
Key Dates
The next earnings report is expected on Jan 11, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Jan 11, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.5x and 0.7x. Its year-end P/S ranged from 0.4x to 20.5x from 2021 to 2025.
| P/S Ratio | 0.5x |
|---|---|
| Forward P/S | 0.5x |
| P/B Ratio | 0.7x |
Price Statistics
The stock is down 32.48% over 52 weeks and trades 15.73% below its 50-day average.
| Beta (1Y) | 1.84 |
|---|---|
| 52-Week Change | -32.48% |
| 1-Month Change | -16.84% |
| 3-Month Change | -26.51% |
| 6-Month Change | -18.13% |
| 5-Year Change | -99.50% |
| Total Return (1Y) | -32.48% |
| Total Return (3Y CAGR) | -65.56% |
| Total Return (5Y CAGR) | -66.41% |
| Return vs SPY (1Y) | -47.98% |
| Max Drawdown (1Y) | -47.89% |
| Max Drawdown (3Y) | -96.83% |
| Sharpe Ratio (1Y) | -0.52 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $3.75 |
| 200-Day Average | $4.08 |
| 52-Week Range | $2.84 to $6.49 |
| RSI (14 Days) | 32.5 |
| Average Volume (20 Days) | 95.17K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.86x current liabilities, and total debt is 1.19x shareholder equity.
| Current Ratio | 4.86x |
|---|---|
| Quick Ratio | 3.85x |
| Debt / Equity | 1.19x |
| Interest Coverage | -4.12x |
Returns and Efficiency
Return on invested capital is -31.02% over the last 12 months, against a 5-year average of -45.24%.
| Return on Equity (ROE) | -85.39% |
|---|---|
| Return on Assets (ROA) | -30.88% |
| Return on Invested Capital (ROIC) | -31.02% |
| Return on Capital Employed (ROCE) | -30.49% |
| ROA (5Y Average) | -40.31% |
| ROIC (5Y Average) | -45.24% |
| Asset Turnover | 0.48x |
| Inventory Turnover | 1.53x |
| Receivables Turnover | 4.09x |
| Cash Conversion Cycle | 305 days |
Scores
OM has an Altman Z-Score of -6.58, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -6.58 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $121.97M over the last 12 months is up 1.58% from the 12 months before.
| Revenue | $121.97M |
|---|---|
| Revenue Growth (YoY) | +1.58% |
| Gross Profit | $51.28M |
| Operating Income | -$62.49M |
| Pretax Income | -$70.45M |
| Net Income | -$71.14M |
| EBITDA | -$55.44M |
| EBIT | -$56.70M |
| Reported EPS (TTM) | -$3.38 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 36.16% of the $230.41M in total assets.
| Cash and Equivalents | $33.94M |
|---|---|
| Total Debt | $99.44M |
| Net Debt | $65.49M |
| Net Debt Per Share | $3.48 |
| Working Capital | $171.77M |
| Shareholder Equity | $83.31M |
| Book Value Per Share | $4.42 |
| Total Assets | $230.41M |
| Total Liabilities | $147.09M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $508.00K of capital spending, operating cash flow left -$42.89M of free cash flow.
| Operating Cash Flow | -$42.38M |
|---|---|
| Capital Expenditures | $508.00K |
| Free Cash Flow | -$42.89M |
| FCF Per Share | -$2.28 |
| Depreciation and Amortization | $4.68M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -51.24%.
| Gross Margin | 42.04% |
|---|---|
| Operating Margin | -51.24% |
| Pretax Margin | -57.76% |
| Net Margin | -58.33% |
| EBITDA Margin | -45.45% |
| EBIT Margin | -46.49% |
| FCF Margin | -35.16% |
| Gross Margin (5Y Average) | 23.63% |
Growth
Revenue grew 1.17% a year over 3 years.
| Revenue Growth (3Y CAGR) | +1.17% |
|---|---|
| Revenue Growth (5Y CAGR) | +19.06% |
Dividends and Yields
OM does not pay a dividend. Its free cash flow yield is -72.07%.
| FCF Yield | -72.07% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-15 reverse split on Mar 20, 2025.
| Last Split Date | Mar 20, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Peer Position
Against 12 similar companies, OM has the 12th highest P/S.
P/S RatioPeer median 1.7x
ROICPeer median -51.95%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.06%
| P/S Ratio | 0.5x vs 1.7x median |
|---|---|
| ROIC | -31.02% vs -51.95% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +1.58% vs +11.06% median |
Analyst Forecast
Consensus estimates put revenue growth at 8.20% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +8.20% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OM
What is OM's market cap?
Outset Medical has a market cap of $63.98M. Its enterprise value, which adds debt and subtracts cash, is $129.47M.
How many shares of OM are outstanding?
Outset Medical has 18.83M shares outstanding. The count is up 5.89% from a year earlier.
Does OM pay a dividend?
No. Outset Medical does not pay a dividend.
How much debt does OM have?
Outset Medical has $99.44M of total debt and $33.94M of cash and equivalents, a net debt position of $65.49M.
OM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors